Changes in the level of 5-HT in both the central and peripheral regions of migraine patients affect the corresponding receptors, which also leads to functional disorders in the gastrointestinal receptors, thereby increasing the risk of gastrointestinal diseases. Here, HTR5A is linked to gastrointestinal disease.